Scarica l'app Stockscreener
0.5647
0.93%
-0.0053
Dopo l'orario di chiusura:
.56
-0.0047
-0.83%
Precedente Chiudi:
$0.57
Aprire:
$0.57
Volume 24 ore:
672.43K
Relative Volume:
0.06
Capitalizzazione di mercato:
$24.97M
Reddito:
$106.79M
Utile/perdita netta:
$-8.73M
Rapporto P/E:
-2.8235
EPS:
-0.2
Flusso di cassa netto:
$10.81M
1 W Prestazione:
+25.24%
1M Prestazione:
+14.31%
6M Prestazione:
-67.55%
1 anno Prestazione:
-83.14%
Intervallo 1D:
$0.55
$0.58
Intervallo di 1 settimana:
$0.443
$0.64
Portata 52W:
$0.2813
$3.43
Harvard Bioscience Inc Stock (HBIO) Company Profile
Nome
Harvard Bioscience Inc
Settore
Industria
Telefono
(508) 893-8999
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Confronta HBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.5647 | 25.20M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
495.86 | 175.16B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.32 | 52.63B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.86 | 45.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
275.16 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
263.51 | 20.05B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Iniziato | Northland Capital | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Downgrade | Janney | Buy → Neutral |
| 2018-01-24 | Reiterato | Janney | Buy |
| 2018-01-23 | Reiterato | The Benchmark Company | Buy |
| 2016-11-17 | Iniziato | Singular Research | Buy |
| 2015-07-28 | Iniziato | The Benchmark Company | Buy |
Mostra tutto
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
What analysts say about Harvard Bioscience Inc. stockMarket-leading growth rates - Autocar Professional
What makes Harvard Bioscience Inc. stock price move sharplyFree Access to Investment Community - Newser
What makes Harvard Bioscience Inc. stock attractive to long term investorsSkyrocketing returns - jammulinksnews.com
Why Harvard Bioscience Inc. stock attracts strong analyst attentionDouble Profit With Half Risk - Newser
What drives Harvard Bioscience Inc. stock priceHigh-performance investment picks - Autocar Professional
Does Harvard Bioscience (NASDAQ:HBIO) Have A Healthy Balance Sheet? - simplywall.st
Is Harvard Bioscience Inc. a good long term investmentExceptional gains - jammulinksnews.com
Harvard Bioscience Inc. Stock Analysis and ForecastBreakout portfolio performance - jammulinksnews.com
Harvard Bioscience announces CEO succession plan - MSN
Harvard Bioscience stock holds Speculative Buy rating at Benchmark - Investing.com India
Harvard Bioscience stock holds Speculative Buy rating at Benchmark By Investing.com - Investing.com Canada
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewswire
John Duke Appointed CEO of Harvard Bioscience - citybiz
Harvard Bioscience Announces CEO Succession Plan - TipRanks
Harvard Bioscience names John Duke as new CEO as Jim Green retires By Investing.com - Investing.com South Africa
Harvard Bioscience names John Duke as new CEO as Jim Green retires - Investing.com
Harvard Bioscience Announces John Duke as New President & CEO Following Jim Green's Retirement and Appoints Rob Gagnon and Seth Benson to Board of Directors - Quiver Quantitative
How Harvard Bioscience Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser
Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
5.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):